hotspot -WSS

hotspot

author：leisure time 2025-10-02 04:36:57 - browse：39381

Sen. Bernie Sanders, I-Vt., chairman of the Senate Health, Education, Labor, and Pensions Committee listens during a hearing on Capitol Hill in Washington – politics and policy coverage from STAT — Senate health committee Chair Bernie Sanders (I-Vt.) wants to reward new medicines with prize money. Jose Luis Magana/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to do away with drug patents and other intellectual property protections in favor of rewarding inventions with prize money. Sanders has been pushing the prize approach since he was a House representative, many years ago.

The measure directing the National Academies of Sciences, Engineering and Medicine to study the idea was added to the Pandemic All-Hazards and Preparedness Act a day before Sander’s health committee passed the bill. Three Republicans voted against the overall bill, which renews several federal biodefense and pandemic-preparedness programs.

Though Democrats last year passed historic legislation to let Medicare negotiate drug prices and cap seniors’ annual out-of-pocket drug costs, Sanders is demanding more drug price controls. He is delaying President Biden’s pick for running the National Institutes of Health until the president releases a plan to control drug prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Medicare Advantage plans can’t deny care with AI, CMS warns

WSS

Albert Bourla of Pfizer: worst biopharma CEO of 2023

340B reform proposal comes out of Senate working group

Editas, Vertex strike deal on CRISPR

AstraZeneca stays mum on Medicare drug pricing negotiations

Why health records don't always know when patients are dead

How to keep neuroscience’s past racism from being its future

explore

hotspot

explore

Dobbs anniversary: the lost opportunity of abortion as health care

How to keep neuroscience’s past racism from being its future

FDA approval of Sarepta Duchenne genetic therapy gives me hope

SEC charges former device maker CEO with $41 million fraud

Apple is now the first public company to be valued at $3 trillion

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Virtual care provider acquires bankrupt Pear's prescription apps

At least 13 dead in Texas as scorching temps continue

How to keep neuroscience’s past racism from being its future

explore

CRISPR gene editing developments we’re watching in 2024

Why health care costs have stayed mostly flat since 2010

Adopting new red light myopia treatments may be short

CRISPR gene editing developments we’re watching in 2024

Surgery pushed Ben Carson to fame

Readout LOUD: Venture capital, Gilead, and more M&A

hotspot

entertainment

focus

explore